This site is intended for healthcare professionals in Saudi Arabia




Sign In / RegisterSign Out Pfizer MedicinesTherapy AreasExplore ContentEvents HubMaterialsVideosOvid DiscoveryLet's ConnectContact UsMedical Inquiries

       Adverse event reporting can be found at the bottom of the page

Welcome to PfizerPro Register hereLoadingRecognize the Signs 

Cardiac amyloidosis is serious condition characterized by the deposition of abnormal proteins called amyloids in the heart tissue. It can lead to progressive heart failure and other cardiovascular complications. Managing cardiac amyloidosis requires a multidisciplinary approach involving various medical specialists.
Recognize the Signs meeting on Cardiac Amyloidosis provide HCPs with valuable insights into the ATTR-CM patient journey. Starting from suspension, diagnosis and ending by the management.
By staying updated through these educational sessions, medical professionals can enhance their ability to provide optimal care to patients with cardiac amyloidosis.

Date: 16th September, 2023
Time: 10:00 AM (GMT+3)

Register here for the EventLoading

This image is for representation purposes only

Register NowLoading
Our Medicines

We provide treatment insights, medicine information to support healthcare professionals.

Our Medicines
Contact Us

Medical Information is here to support you with your product information inquiries.

Contact Us
Therapy Areas

Information relating to specific disease areas aligned to Pfizer's portfolio

Therapy Areas
Sign In / RegisterLoading
Journey for Health Suspect & Detect 

I am looking for :

Free Subscription to peer reviewed Journals Subscribe Freely Now  Loading Browse and register for speaker programs Search &/ Register Loading  Visit Pfizer on LinkedIn

Visit  Loading
Find resources for you and your patients View Materials now  Loading View up to date Medicines information View Products  LoadingDiscover science and evidence behind medicines& Therapy areas View Therapy areas  Loading Visit Pfizer on TwitterVisitLoading Visit Pfizer on Instagram VisitLoadingVisit Pfizer on Facebook VisitLoading
Search Our Scientific Database

Search through our scientific database and find the response to your Medical Information enquiry on a Pfizer product.

Click HereLoading
Publications Update

Subscribe to receive a comprehensive and timely compilation of the latest scientific journal articles on various therapy areas.


Pfizer Saudi ArabiaLoading
Pfizer Saudi Arabia
Saudi Heamahub Paxlovid Explore ContentEvents Hub

Browse and register for speaker programs


View resources for you and your patients


Find videos and on-demand webinars

Congress Materials

Explore selected congresses, congress materials, therapeutic and disease areas.

Contact Pfizer Medical Information

Pfizer Medical Information is here to support you with your product medical inquiries.

Contact Us

Report Adverse Events

Please send us an email if you want to report an adverse event, email your enquiry to [email protected]

Pfizerpro account

Access Pfizer materials, resources and receive communications from Pfizer about our products with a Pfizerpro account.

Sign In or Register
Please click here to contact Pfizer customer support.

Representatives are available Sun -Thu | 9 AM - 5 PM, excluding public holidays.

Copyright © 2024 Pfizer Inc. All rights reserved.

For Health Care Professionals Only

This information is intended only for Healthcare professionals in Saudi Arabia. The product information provided in this site is intended only for Healthcare professionals in Saudi Arabia. The products discussed herein may have different product labeling in different countries. Pfizer Inc does not suggest or recommend the use of Pfizer products in any manner other than as described in the Prescribing information approved by Saudi Food and Drug Administration (SFDA). Pfizer Scientific Technical Limited Company is a subsidiary of Pfizer Inc., a pharmaceutical company committed to helping people improve their health by discovering and developing medicines.
You are now leaving PfizerPro​​​​​

You are leaving the Pfizer Portal - Would you like to continue?​​​​​​​
You are now leaving PfizerPro​​​​​ You are leaving the Pfizer Portal - Would you like to continue?